Search research articles
Contact Us
Filters
Showing results (261-270 of 361) with videos related to
Page
of 37
Sort By:
Psychiatry Research
|
February 1, 1984
Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activity
T P Bridge, D V Jeste, C D Wise, et al.
Inorganic Chemistry
|
April 2, 2016
Carboxylic Acid Functionalized Clathrochelate Complexes: Large, Robust, and Easy-to-Access Metalloligands
Mathieu Marmier, Matthew D Wise, Julian J Holstein, et al.
CHEST Critical Care
|
December 23, 2024
Operationalizing the New Global Definition of ARDS: A Retrospective Cohort Study From South Africa
George L Anesi, Arisha Ramkillawan, Jonathan Invernizzi, et al.
Journal of Neurophysiology
|
August 9, 2003
Massively parallel recording of unit and local field potentials with silicon-based electrodes
Jozsef Csicsvari, Darrell A Henze, Brian Jamieson, et al.
Journal of Neural Engineering
|
August 30, 2013
An implantable neural probe with monolithically integrated dielectric waveguide and recording electrodes for optogenetics applications
Fan Wu, Eran Stark, Maesoon Im, et al.
Biological Psychiatry
|
December 1, 1980
Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia
L E DeLisi, C D Wise, S G Potkin, et al.
The Southern African Journal of Critical Care : the Official Journal of the Critical Care Society
|
May 2, 2022
qSOFA as a predictor of ICU outcomes in a resource-limited setting in KwaZulu-Natal Province, South Africa
S M Savarimuthu, C Cairns, N L Allorto, et al.
Journal of Medicinal Chemistry
|
September 5, 2003
Orally active oxime derivatives of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Synthesis and pharmacological activity
Bastiaan J Venhuis, Durk Dijkstra, David Wustrow, et al.
Journal of Medicinal Chemistry
|
September 1, 1991
Dopamine autoreceptor agonists as potential antipsychotics. 3.6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine
B W Caprathe, J C Jaen, L D Wise, et al.
Journal of Medicinal Chemistry
|
May 5, 2000
Subtype-selective N-methyl-D-aspartate receptor antagonists: benzimidazalone and hydantoin as phenol replacements
R M Schelkun, P W Yuen, K Serpa, et al.
Page
of 37
Search research articles
Search
Showing results (261-270 of 361) with videos related to
Sort By:
Page
of 37
Psychiatry Research
|
February 1, 1984
Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activity
T P Bridge, D V Jeste, C D Wise, et al.
Inorganic Chemistry
|
April 2, 2016
Carboxylic Acid Functionalized Clathrochelate Complexes: Large, Robust, and Easy-to-Access Metalloligands
Mathieu Marmier, Matthew D Wise, Julian J Holstein, et al.
CHEST Critical Care
|
December 23, 2024
Operationalizing the New Global Definition of ARDS: A Retrospective Cohort Study From South Africa
George L Anesi, Arisha Ramkillawan, Jonathan Invernizzi, et al.
Journal of Neurophysiology
|
August 9, 2003
Massively parallel recording of unit and local field potentials with silicon-based electrodes
Jozsef Csicsvari, Darrell A Henze, Brian Jamieson, et al.
Journal of Neural Engineering
|
August 30, 2013
An implantable neural probe with monolithically integrated dielectric waveguide and recording electrodes for optogenetics applications
Fan Wu, Eran Stark, Maesoon Im, et al.
Biological Psychiatry
|
December 1, 1980
Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia
L E DeLisi, C D Wise, S G Potkin, et al.
The Southern African Journal of Critical Care : the Official Journal of the Critical Care Society
|
May 2, 2022
qSOFA as a predictor of ICU outcomes in a resource-limited setting in KwaZulu-Natal Province, South Africa
S M Savarimuthu, C Cairns, N L Allorto, et al.
Journal of Medicinal Chemistry
|
September 5, 2003
Orally active oxime derivatives of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Synthesis and pharmacological activity
Bastiaan J Venhuis, Durk Dijkstra, David Wustrow, et al.
Journal of Medicinal Chemistry
|
September 1, 1991
Dopamine autoreceptor agonists as potential antipsychotics. 3.6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine
B W Caprathe, J C Jaen, L D Wise, et al.
Journal of Medicinal Chemistry
|
May 5, 2000
Subtype-selective N-methyl-D-aspartate receptor antagonists: benzimidazalone and hydantoin as phenol replacements
R M Schelkun, P W Yuen, K Serpa, et al.
Page
of 37